Pinetree Therapeutics has raised $47 million in an oversubscribed Series B round to advance next-generation protein degraders in oncology.
Amount Raised
$47 Million
Round Type
Series B
CambridgeBiotechnologyHealth CareScience And EngineeringInvestors
Description
Pinetree Therapeutics has successfully completed an oversubscribed Series B funding round, raising $47 million. The capital will be utilized to advance their next-generation protein degraders aimed at treating oncology patients. This significant investment underscores the growing interest in innovative cancer therapies. The funding round was led by prominent investors in the biotech sector.
Quick answer
PineTree Therapeutics raised $47 Million in a Series B round, dated October 29, 2025. Investors: Gauss Capital Management and STIC Ventures. PineTree Therapeutics is based in Cambridge, Massachusetts, United States.
- How much did PineTree Therapeutics raise?
- PineTree Therapeutics raised $47 Million in a Series B round on October 29, 2025.
- Who invested in PineTree Therapeutics?
- Gauss Capital Management and STIC Ventures are named as investors in this round.
- What does PineTree Therapeutics do?
- Pinetree Therapeutics, based in Cambridge, MA, is a preclinical-stage biotech company developing next-generation targeted protein degraders (TPDs) to overcome drug resistance and tumor recurrence in oncology, with..
- Where is PineTree Therapeutics based and how big is it?
- PineTree Therapeutics is based in Cambridge, Massachusetts, United States. Fundz records about 36 employees.
- Who are the decision-makers at PineTree Therapeutics?
- Fundz holds 1 contact at PineTree Therapeutics, including the CEO/Founder. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as PineTree Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Enveric Biosciences raised $107K on December 12, 2025.
- Aprea Therapeutics raised $3.1M on December 10, 2025.
- TandemAI raised $22M (Series A) on November 14, 2025.
- Equillium raised $50M (Funding Round) on November 13, 2025.
- Electra Therapeutics raised $183M (Series C) on October 22, 2025.
- RedHill Biopharma Ltd raised $4M (Corporate Round) on October 20, 2025.
Who to call at PineTree Therapeutics, and when
A new round usually means PineTree Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day PineTree Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PineTree Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PineTree Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PineTree Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansPineTree Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.